Visual loss and optic atrophy associated with cyproterone acetate.
Markus
H
H
Department of Neurology, Middlesex Hospital, London.
Polkey
M
M
Harrison
M
M
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003534:Cyproterone / Q000009:adverse effects / Q000031:analogs & derivatives*; D017373:Cyproterone Acetate; D006801:Humans; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced*; D014786:Vision Disorders / Q000139:chemically induced*
D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D003534:Cyproterone